Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, November 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Irvine Scientific Introduces DMSO-Free
Wednesday, November 19, 2014
A chemically-defined cryopreservation solution for mesenchymal stem cells.

PRIME-XV® FreezIS DMSO-Free Launched
Tuesday, November 18, 2014
Irvine Scientific introduces DMSO-Free, chemically-defined cryopreservation solution for mesenchymal stem cells.

BioCision Announces Industry’s First Automated Biospecimen Thawing System
Wednesday, November 12, 2014
Intelligent device utilizes adaptive sensing technology for accurate and standardized thawing.

Top Ten Pharma Uses Time Saving Fill-it System in Biologics Manufacturing
Friday, November 07, 2014
To assure consistent quality cell banks and reference standards at half the cost.

Nanolive, The Future Of Living Cell Microscopy
Monday, November 03, 2014
Nanolive SA has developed a revolutionary microscope which, for the very first time, allows the exploration of a living cell in 3D without damaging it.

Blood-Derived Products for Personalized Medicine Research
Tuesday, October 21, 2014
Blood-derived products includes whole blood, serum, plasma, buffy coat and peripheral blood mononuclear cells.

Versatile Code Reading Software for Sample Storage
Saturday, October 04, 2014
New software is easy to install, gives reliable code readings and can be smoothly integrated into any laboratory sample database.

New Mosaic 6.0 Makes Sample Management More Intuitive and Cost-effective
Tuesday, September 30, 2014
Latest version of Titian’s Mosaic software drives major increase in sample management efficiency.

New CombiCult® Technology Massively Accelerates Development of Stem Cell Cures
Friday, September 26, 2014
CombiCult® technology enables a single scientist to carry out 10,000 stem cell biology experiments in parallel.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 489
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv